文献速递神经MR

中度肾衰竭可加重钆双胺处理大鼠小脑深部核团的T1信号增强

Moderate Renal Failure Accentuates T1 Signal Enhancement in the Deep Cerebellar Nuclei of Gadodiamide-Treated Rats.
PubMed 文献 · Invest Radiol · 2017-01-01

该临床前研究比较了次全肾切除所致肾功能不全大鼠与肾功能正常大鼠,每周4次注射0.6 mmol Gd/kg钆双胺共5周(累积剂量12 mmol Gd/kg),每周行MRI监测小脑深部核团信号增强,末次注射后1周用ICP-MS测定脑各区域钆浓度。结果显示肾切除组小脑深部核团T1信号增强显著高于肾功能正常组,所有研究结构的钆总浓度也大幅升高,且脑、小脑、血浆和骨钆浓度与肌酐清除率相关。

要点

  • 肾功能不全大鼠在相同线性钆对比剂累积剂量下,小脑深部核团T1信号增强显著高于肾功能正常大鼠。
  • 肾切除组脉络丛出现明显高信号,末次注射后6天仍持续存在。
  • 脑、小脑、血浆和骨钆总浓度均与肌酐清除率相关。

核心结论

  • 大鼠肾功能不全会促进钆在小脑、脑和骨中的蓄积。

研究设计与样本

  • 临床前比较研究,比较次全肾切除所致肾功能不全大鼠与肾功能正常大鼠,动物每周接受4次0.6 mmol Gd/kg钆双胺或生理盐水注射共5周(累积剂量12 mmol Gd/kg),每周行MRI监测,末次注射后1周用电感耦合等离子体质谱测定脑、小脑、血浆、脑脊液、顶骨和股骨等区域钆总浓度。

关键影像表现/征象

  • 肾切除组小脑深部核团T1信号增强显著高于接受相同线性钆对比剂的肾功能正常组。
  • 肾切除组脉络丛出现明显高信号,末次注射后6天仍持续存在。
  • 末次注射后6天脑脊液钆浓度低(<0.05 μmol/L),此时血浆钆浓度约1 μmol/L。
  • 血浆钆主要以解离可溶形式存在(约占总钆90%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The purpose of this preclinical study was to investigate whether moderate chronic kidney disease is a factor in potentiating gadolinium (Gd) uptake in the brain.

MATERIALS AND METHODS: A comparative study was performed on renally impaired (subtotal nephrectomy) rats versus rats with normal renal function. The animals received 4 daily injections of 0.6 mmol Gd/kg a week for 5 weeks (cumulative dose of 12 mmol Gd/kg) of gadodiamide or saline solution. The MR signal enhancement in the deep cerebellar nuclei was monitored by weekly magnetic resonance imaging examinations. One week after the final injection, the total Gd concentration was determined by inductively coupled plasma mass spectrometry in different regions of the brain including the cerebellum, plasma, cerebrospinal fluid, parietal bone, and femur.

RESULTS: After the administration of gadodiamide, the subtotal nephrectomy group presented a significantly higher T1 signal enhancement in the deep cerebellar nuclei and a major increase in the total Gd concentration in all the studied structures, compared with the normal renal function group receiving the same linear Gd-based contrast agent. Those potentiated animals also showed a pronounced hypersignal in the choroid plexus, still persistent 6 days after the last injection, whereas low concentration of Gd was found in the cerebrospinal fluid (<0.05 μmol/L) at this time point. Plasma Gd concentration was then around 1 μmol/L. Interestingly, plasma Gd was predominantly in a dissociated and soluble form (around 90% of total Gd). Total Gd concentrations in the brain, cerebellum, plasma, and bones correlated with creatinine clearance in both the gadodiamide-treated groups.

CONCLUSIONS: Renal insufficiency in rats potentiates Gd uptake in the cerebellum, brain, and bones.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Rasschaert M, Idée JM, Robert P, et al. Moderate Renal Failure Accentuates T1 Signal Enhancement in the Deep Cerebellar Nuclei of Gadodiamide-Treated Rats. Invest Radiol. 2017. PMID: 28067754. doi:10.1097/RLI.0000000000000339

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。